Montero S - Search Results

1

Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer.

Colomer R, Montero S, Lluch A, Ojeda B, Barnadas A, Casado A, Massutí B, Cortés-Funes H, Lloveras B. Colomer R, et al. Among authors: montero s. Clin Cancer Res. 2000 Jun;6(6):2356-62. Clin Cancer Res. 2000. PMID: 10873087 Clinical Trial.

2

Trastuzumab plus tamoxifen: anti-proliferative and molecular interactions in breast carcinoma.

Ropero S, Menéndez JA, Vázquez-Martín A, Montero S, Cortés-Funes H, Colomer R. Ropero S, et al. Among authors: montero s. Breast Cancer Res Treat. 2004 Jul;86(2):125-37. doi: 10.1023/b:brea.0000032981.20384.c6. Breast Cancer Res Treat. 2004. PMID: 15319565

3

Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma.

Colomer R, Aparicio J, Montero S, Guzmán C, Larrodera L, Cortés-Funes H. Colomer R, et al. Among authors: montero s. Br J Cancer. 1997;76(9):1215-20. doi: 10.1038/bjc.1997.536. Br J Cancer. 1997. PMID: 9365172 Free PMC article.

4

Angiogenin expression and prognosis in primary breast carcinoma.

Montero S, Guzmán C, Cortés-Funes H, Colomer R. Montero S, et al. Clin Cancer Res. 1998 Sep;4(9):2161-8. Clin Cancer Res. 1998. PMID: 9748135

5

Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain.

Colomer R, Llombart-Cussac A, Lluch A, Barnadas A, Ojeda B, Carañana V, Fernández Y, García-Conde J, Alonso S, Montero S, Hornedo J, Guillem V. Colomer R, et al. Among authors: montero s. Ann Oncol. 2004 Feb;15(2):201-6. doi: 10.1093/annonc/mdh048. Ann Oncol. 2004. PMID: 14760109 Free article. Clinical Trial.

6

Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells.

Menéndez JA, Ropero S, del Barbacid MM, Montero S, Solanas M, Escrich E, Cortés-Funes H, Colomer R. Menéndez JA, et al. Among authors: montero s. Breast Cancer Res Treat. 2002 Apr;72(3):203-19. doi: 10.1023/a:1014968415759. Breast Cancer Res Treat. 2002. PMID: 12058962

7

Correspondence re: S. Shimoyama et al., increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression. Clin. Cancer Res., 5: 1125-1130, 1999.

Montero S, Lloveras B, Cortés-Funes H, Colomer R. Montero S, et al. Clin Cancer Res. 1999 Nov;5(11):3722-3. Clin Cancer Res. 1999. PMID: 10589792 No abstract available.

8

Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells.

Menéndez JA, del Mar Barbacid M, Montero S, Sevilla E, Escrich E, Solanas M, Cortés-Funes H, Colomer R. Menéndez JA, et al. Among authors: montero s. Eur J Cancer. 2001 Feb;37(3):402-13. doi: 10.1016/s0959-8049(00)00408-1. Eur J Cancer. 2001. PMID: 11239764

9

Prognostic value of cytosolic p53 protein in breast cancer.

Montero S, Guzmán C, Vargas C, Ballestín C, Cortés-Funes H, Colomer R. Montero S, et al. Tumour Biol. 2001 Sep-Oct;22(5):337-44. doi: 10.1159/000050636. Tumour Biol. 2001. PMID: 11553865

10

CCR5 expression influences the progression of human breast cancer in a p53-dependent manner.

Mañes S, Mira E, Colomer R, Montero S, Real LM, Gómez-Moutón C, Jiménez-Baranda S, Garzón A, Lacalle RA, Harshman K, Ruíz A, Martínez-A C. Mañes S, et al. Among authors: montero s. J Exp Med. 2003 Nov 3;198(9):1381-9. doi: 10.1084/jem.20030580. J Exp Med. 2003. PMID: 14597737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters